US2002048565A1PendingUtilityA1
Mammalian tolloid-like gene and protein
Priority: May 30, 1996Filed: Aug 29, 2001Published: Apr 25, 2002
Est. expiryMay 30, 2016(expired)· nominal 20-yr term from priority
A61K 38/00C07K 14/51A61K 48/00A61P 43/00C12N 15/11
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A mammalian gene encoding a tolloid-like protein distinct from human or murine BMP-1/mTld is presented. The gene is similar in structure to members of the BMP-1 family of genes, but maps to a distinct location and encodes a distinct protein. The protein encoded by the gene can be used to screen putative therapeutic agents in an ongoing effort to inhibit activity of the BMP-1 family of genes to prevent scarring, fibrosis, and the like.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A substantially purified preparation of a DNA molecule comprising the nucleotide sequence of SEQ ID NO:2 between nucleotides 1052 and 3649.
2 . A genetic construct comprising in 5′ to 3′ order:
a transcriptional promoter active in a host cell; and
a DNA fragment comprising a nucleotide sequence of SEQ ID NO:2 between nucleotides 1052 and 3649.
3 . A method for treating a wound, comprising the steps of:
providing in a suitable host cell a genetic construct comprising a transcriptional promoter active in the host cell and a DNA fragment comprising a nucleotide sequence of SEQ ID NO:2 between nucleotides 1052 and 3649 so that a protein is encoded by the nucleotide sequence; and administering the protein to a wound in an amount effective to accelerate healing of the wound relative to an untreated wound.
4 . A substantially pure preparation of a protein having the amino acid sequence of SEQ ID NO:3 between amino acids 1 and 1013.
5 . A substantially purified preparation of a DNA molecule comprising the nucleotide sequence of SEQ ID NO:4 between nucleotides 1089 and 3686.
6 . A genetic construct comprising in 5′ to 3′ order:
a transcriptional promoter active in a host cell; and
a DNA fragment comprising a nucleotide sequence of SEQ ID NO:4 between nucleotides 1089 and 3686.
7 . A method for treating a wound, comprising the steps of:
providing in a suitable host cell a genetic construct comprising a transcriptional promoter active in the host cell and a DNA fragment comprising a nucleotide sequence of SEQ ID NO:4 between nucleotides 1089 and 3686 so that a protein is encoded by the nucleotide sequence; and administering the protein to a wound in an amount effective to accelerate healing of the wound relative to an untreated wound.
8 . A substantially pure preparation of a protein having the amino acid sequence of SEQ ID NO:5 between amino acids 1 and 1013.Join the waitlist — get patent alerts
Track US2002048565A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.